human red blood cells treated with the cuzn superoxide dismutase inhibitor diethyldithiocarbamate ( ddc ) undergo metabolic modifications in addition to the superoxide dismutase inhibition : oxidation of the reduced glutathione ( gsh ) to oxidized glutathione ( gssg ) , methemoglobin formation , and increased hexose monophosphate shunt activity were observed .
C0017817
gsh
C0061516
gssg